701 E. Hampden Ave., Ste. 518
Englewood, CO 80113
phone 303-788-7667
fax 303-409-6800
email abneurocare@qwestoffice.net
1982 B.S. Yale College, Summa Cum Laude, Phi Beta Kappa
1988 M.D. Yale University School of Medicine
1988 Ph.D. Dept. of Pharmacology, Yale University School of Medicine
1988-1989 Internship, Internal Medicine Department, University of California – San Francisco
1989-1992 Residency, Neurology Department, University of California – San Francisco
1992-1995 Fellowship, Neurology Service, Massachusetts General Hospital and Harvard Medical School
1996-present University of Colorado, Neurology Dept, Aurora, CO
1996-1997 -Clinical Instructor
1997-2003 -Assistant Clinical Professor
2003-2012 -Associate Clinical Professor
2012-present -Clinical Professor
1997-2008 Rocky Mountain MS Center, Englewood, CO
1997-2008 -Director, Complementary and Alternative Medicine Program
1997-2002 -Associate Medical Director
2003-2007 -Medical Director
2009-2018 Colorado Neurological Institute (CNI)
2009-2014 -Medical Director, Multiple Sclerosis Program
2009-2014 -Medical Director, Complementary and Alternative Medicine Service
2014-2018 -Chair of Education
2014-2018 -Medical Advisory Committee
2014-2018 -Physician Associate
2006-2013 Editorial Board: Multiple Sclerosis Journal (formerly Multiple Sclerosis), Sage Publications
2007-2014 Member, Quality Standards Subcommittee of the American Academy of Neurology (AAN)
2007-2015 Member, Committee for the Strauss-Wisneski Indigenous and Integrative Medicine Collection, University of Colorado
2009-2013 Advisor, Guthy-Jackson Charitable Foundation, San Diego, CA
2012-2017 Grant Reviewer, Patient Management, Care, and Rehabilitation Pilot Review Committee, National MS Society (NMSS)
2012-2017 Member, Clinical Advisory Committee, Colorado-Wyoming Chapter of the National MS Society (NMSS)
2001-present Member, Healthcare Advisory Council, MS Association of America (MSAA)
2005-present Ad Hoc Grant Reviewer, National MS Society (NMSS)
1995-1997 Western Neurological Group, Denver, CO
1997-2007 Colorado Neurology, Englewood, CO
2007-present Neurology Care, address above
1993-present Board Certification, American Board of Psychiatry and Neurology
1995-present Medical License, Colorado Board of Medical Examiners
2016 Neuroscientist of the Year Award, awarded by Colorado Neurological Institute for groundbreaking visionary work in clinical care, research, and writing
2011 “Top 10 MS Books,” Complementary and Alternative Medicine and Multiple Sclerosis chosen by the Consortium of MS Centers (CMSC) as one of the top 10 lay books on MS
2000 Award for Best Presentation in Patient Education, annual meeting of the Consortium of Multiple Sclerosis Centers
1999 Labe Scheinberg Award, annual meeting of the Consortium of Multiple Sclerosis Centers
1988 American Epilepsy Society Award
1988 Medical Scientist Training Program Student
1987 Saul R. Korey Award in Experimental Neurology (American Academy of Neurology)
1982 Summa Cum Laude, Yale College
1982 Phi Beta Kappa, Yale College
1982 Fellows’ Prize, Yale College
1982 Distinction in Major, Yale College
1982 Scholar of the House, Yale College
1981 Bates’ Summer Traveling Fellowship, Yale College
Click here for the “Lectures” page
Click here for the “Books” page
Click here for the “Articles” page
An Open-Label Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Relapsing Remitting Multiple Sclerosis Who Have Had a Suboptimal Response to an Adequate Course of Disease-modifying Treatment
Principal Investigator
A Prospective Observational Registry of H.P. Acthar Gel for the Treatment of Multiple Sclerosis Relapse.
Principal Investigator
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teiflunomide Treatment using Patient-Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Principal Investigator
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Variable Treatment Duration Study Evaluating the Efficacy and Safety of Siponimod (BAF312) in Patients with Secondary Progressive Multiple Sclerosis
Principal Investigator
A Phase IV, Randomized, Prospective, US-based, Multicenter, Cross-Over Study Evaluating Subject Ease-of-Use with Rebif® Rebidose® and Rebiject II® Autoinjectors in Subjects with Relapsing Remitting Multiple Sclerosis (RRMS) Treated with Rebif® 44mcg Subcutaneously Three Times a Week
Principal Investigator
Plegridy™ (peginterferon β-1a) Real World Effectiveness and Safety Observational Program
Principal Investigator
Botox® Treatment in Adult Patients with Upper Limb Spasticity
Sub-Investigator
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (dimethyl fumarate) Delayed-Release Capsules in Patients with Relapsing Forms of Multiple Sclerosis after Suboptimal response to Glatiramer Acetate
Principal Investigator